Evidence map›Paper›PMID 35205427›Full record

ArticleGenes2022

Alpha Satellite RNA Levels Are Upregulated in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer.

Sven Ljubić, Antonio Sermek, Angela Prgomet Sečan, Marin Prpić, Blanka Jakšić, Jure Murgić, Ana Fröbe, Đurđica Ugarković, Isidoro Feliciello

Abstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Alpha Satellite DNA in Targeted Drug Therapy for Prostate Cancer.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sven LjubićDepartment of Molecular Biology, Ruđer Bošković Institute, Bijenička 54, HR-10000 Zagreb, Croatia.
Antonio SermekDepartment of Molecular Biology, Ruđer Bošković Institute, Bijenička 54, HR-10000 Zagreb, Croatia.ORCID 0000-0002-7402-182X
Angela Prgomet SečanDepartment of Oncology and Nuclear Medicine, University Clinical Hospital Centre (UHC) Sestre Milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia.
Marin PrpićDepartment of Oncology and Nuclear Medicine, University Clinical Hospital Centre (UHC) Sestre Milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia.ORCID 0000-0002-4471-7279
Blanka JakšićDepartment of Oncology and Nuclear Medicine, University Clinical Hospital Centre (UHC) Sestre Milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia.
Jure MurgićDepartment of Oncology and Nuclear Medicine, University Clinical Hospital Centre (UHC) Sestre Milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia.ORCID 0000-0001-8152-0494
Ana FröbeDepartment of Oncology and Nuclear Medicine, University Clinical Hospital Centre (UHC) Sestre Milosrdnice, Vinogradska cesta 29, HR-10000 Zagreb, Croatia.ORCID 0000-0002-5834-9841
Đurđica UgarkovićDepartment of Molecular Biology, Ruđer Bošković Institute, Bijenička 54, HR-10000 Zagreb, Croatia.ORCID 0000-0003-0925-3939
Isidoro FelicielloDepartment of Molecular Biology, Ruđer Bošković Institute, Bijenička 54, HR-10000 Zagreb, Croatia.ORCID 0000-0002-2588-9366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aberrant overexpression of alpha satellite DNA is characteristic of many human cancers including prostate cancer; however, it is not known whether the change in the alpha satellite RNA amount occurs in the peripheral tissues of cancer patients, such as blood. Here, we analyse the level of intracellular alpha satellite RNA in the whole blood of cancer prostate patients at different stages of disease and compare it with the levels found in healthy controls. Our results reveal a significantly increased level of intracellular alpha satellite RNA in the blood of metastatic cancers patients, particularly those with metastatic castration-resistant prostate cancer relative to controls. In the blood of patients with localised tumour, no significant change relative to the controls was detected. Our results show a link between prostate cancer pathogenesis and blood intracellular alpha satellite RNA levels. We discuss the possible mechanism which could lead to the increased level of blood intracellular alpha satellite RNA at a specific metastatic stage of prostate cancer. Additionally, we analyse the clinically accepted prostate cancer biomarker PSA in all samples and discuss the possibility that alpha satellite RNA can serve as a novel prostate cancer diagnostic blood biomarker.

Indexed as

Prostatic Neoplasms, Castration-ResistantBiomarkers, TumorHumansMaleProstateRNA, SatelliteBiomarkers, TumorRNA, Satellitealpha satellite DNAalpha satellite RNAblood biomarkerprostate cancertranscription

Identifiers

PMID35205427
PMCPMC8871578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.